CLALIT HEALTH SERVICES

Their core work

Clalit Health Services is Israel's largest health maintenance organization, serving over 4 million members, and one of the world's largest integrated healthcare systems. In H2020 projects, they contribute real-world clinical data, patient cohorts, and healthcare delivery expertise — particularly in immunology, brain disorders, and cardiovascular medicine. Their participation brings large-scale health records and clinical trial infrastructure to European research consortia, bridging the gap between computational research and clinical validation.

What they specialise in

How they've shifted over time

Clalit's early H2020 involvement (2015–2018) focused on eHealth for elderly populations and informal care policy — practical healthcare delivery challenges. From 2019 onward, their focus shifted decisively toward data-intensive biomedical research: immune repertoire analytics, AI-driven brain disorder diagnosis, and immunotherapy clinical trials. This evolution reflects a move from healthcare IT applications toward becoming a clinical data partner for computational biomedicine and precision medicine consortia.

Clalit is positioning itself as a large-scale clinical data provider for AI and immunology research, making them increasingly relevant for projects needing real-world patient cohorts and federated health data access.

How they like to work

Clalit exclusively participates as a partner — never as coordinator — across all six projects, indicating they contribute domain expertise and clinical infrastructure rather than leading project design. With 113 unique consortium partners across 23 countries, they operate in large, diverse consortia and do not cluster around repeat collaborators. This makes them an accessible partner: experienced in multi-national collaboration, comfortable integrating into existing consortium structures, and not locked into exclusive networks.

Clalit has collaborated with 113 distinct partners across 23 countries, giving them a broad European network despite being based in Israel. Their connections span clinical research networks, AI research groups, and health data federations across the EU.

What sets them apart

Clalit brings something rare to European consortia: access to one of the world's largest integrated health record systems covering millions of patients, combined with clinical trial infrastructure. Unlike university hospitals that contribute narrow specialist cohorts, Clalit offers population-scale health data across multiple disease areas. For any consortium needing real-world clinical validation, patient recruitment, or large-scale health data — particularly in immunology or neurology — they are a distinctive non-EU partner with proven H2020 experience.

Highlights from their portfolio

• MES-CoBraD
  Their largest-funded project (EUR 443,790) combining AI expert systems with multi-source clinical data for complex brain disorders — represents their strategic direction toward computational medicine.
• iReceptor Plus
  Positioned Clalit at the intersection of immunology and federated data infrastructure, contributing to a distributed system for querying immune repertoire data across international repositories.
• RITA-MI 2
  A phase 2 clinical trial repurposing an immunotherapy drug (rituximab) for heart attack patients — an unusual cross-disciplinary application of cancer immunotherapy to cardiovascular disease.